Human Cyr61/CCN1 PharmaGenie ELISA Kit (SBRS0473)

The Human Cyr61/CCN1 PharmaGenie ELISA from Assay Genie quantitatively measures cysteine-rich angiogenic inducer 61 (CCN1), a matricellular signaling protein implicated in wound repair, fibrotic remodeling, tumor angiogenesis, and inflammatory cascade activation. Capture and detection antibodies are specific to the human CCN1 sequence, supporting translational studies profiling circulating biomarkers in plasma/serum, as well as secreted CCN1 levels in conditioned media from endothelial cells, fibroblasts, or tumor-derived cell lines. Researchers commonly deploy this microplate-format kit in cardiovascular and oncology workflows tracking extracellular matrix remodeling, vascular injury response, and fibrotic disease mechanisms. The kit includes a pre-coated plate, lyophilized standards, biotinylated detection antibody, and streptavidin-HRP reagents sufficient for 96 individual determinations; all components should be refrigerated upon receipt to preserve antibody activity across the shelf life of the product. Intended for research use only, the assay provides a sensitive tool for in vitro biomarker quantification. CCN1 cross-reactivity with non-human species has not been formally characterized in this product, supporting its use as a human-specific capture antibody platform for clinical research samples.